Cited by 102Mitochondrial Function and PathologyWnt/β-catenin signaling in development and cancerLiver physiology and pathology

β-Catenin Regulates Hepatic Mitochondrial Function and Energy Balance in Mice

Open access
Lehwald, Nadja, Tao, Guo–Zhong, Jang, Kyu Yun, Papandreou, Ioanna, Liu, Bowen, Liu, Bo, Pysz, Marybeth A., Willmann, Jürgen K. +3 more·2012·Gastroenterology

Abstract

Background & aims Wnt signaling regulates hepatic function and nutrient homeostasis. However, little is known about the roles of β-catenin in cellular respiration or mitochondria of hepatocytes. Methods We investigated β-catenin's role in the metabolic function of hepatocytes under homeostatic conditions and in response to metabolic stress using mice with hepatocyte-specific deletion of β-catenin and their wild-type littermates, given either saline (sham) or ethanol (as a model of binge drinking and acute ethanol intoxication). Results Under homeostatic conditions, β-catenin-deficient hepatocytes demonstrated mitochondrial dysfunctions that included impairments to the tricarboxylic acid cycle and oxidative phosphorylation (OXPHOS) and decreased production of adenosine triphosphate (ATP). There was no evidence for redox imbalance or oxidative cellular injury in the absence of metabolic stress. In mice with β-catenin-deficient hepatocytes, ethanol intoxication led to significant redox imbalance in the hepatocytes and further deterioration in mitochondrial function that included reduced OXPHOS, fatty acid oxidation (FAO), and ATP production. Ethanol feeding significantly increased liver steatosis and oxidative damage, compared with wild-type mice, and disrupted the ratio of nicotinamide adenine dinucleotide. β-catenin-deficient hepatocytes also had showed disrupted signaling of Sirt1/peroxisome proliferator-activated receptor-α signaling. Conclusions β-catenin has an important role in the maintenance of mitochondrial homeostasis, regulating ATP production via the tricarboxylic acid cycle, OXPHOS, and fatty acid oxidation; β-catenin function in these systems is compromised under conditions of nutrient oxidative stress. Reagents that alter Wnt-β-catenin signaling might be developed as a useful new therapeutic strategy for treatment of liver disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2012.05.048

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HSC-derived RSPO3, hepatocyte-expressed LGR4 and its downstream target β-catenin are central mediators of the HSC-hepatocyte cross-talk that controls liver size, zonation and function.

    “Thus, Rspo3ΔHSC mice reproduced key aspects of HSC-depleted, Lgr4/Lgr5ΔHep and Ctnnb1ΔHep mice24,25,34–39, suggesting HSC-derived RSPO3, hepatocyte-expressed LGR4 and its downstream target β-catenin as central mediators of the HSC–hepatocyte cross-talk that controls liver size, zonation and function.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [37]

    The Results (page not provided) show that hepatocyte-specific β-catenin deletion impairs mitochondrial function and energy production; the Discussion also notes a reduced liver-to-body-weight ratio in β-catenin-deficient mice. These findings support a role for β-catenin in liver size and function, but the paper does not establish RSPO3–LGR4 signaling, HSC–hepatocyte cross-talk, or the proposed control of zonation. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • RSPO3 has seemingly opposing functions in acute toxic liver and chronic metabolic injury, aligning with the functions of its downstream target β-catenin in hepatocyte injury.

    “The seemingly opposing functions of RSPO3 in acute toxic liver and chronic metabolic injury align with the functions of its downstream target β-catenin in hepatocyte injury34–39.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [37]

    The Results (page unavailable) show that β-catenin-deficient mice had greater hepatocellular injury after acute ethanol intoxication. The Discussion (page unavailable) also reports increased steatohepatitis after β-catenin deletion in an MCD-diet model. These passages support a role for β-catenin in hepatocyte injury, but not the claimed opposing functions across acute toxic and chronic metabolic injury; they do not address RSPO3. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • HSC-derived RSPO3 critically impacts liver size, zonation, metabolism, regeneration and injury.

    “The critical impact of HSC-derived RSPO3 on liver size, zonation, metabolism, regeneration and injury matches findings in mice with hepatocyte-specific deletion of β-catenin or LGR4/524,25,34–39, rendering RSPO3–LGR4-mediated HSC–hepatocyte communication a gatekeeper of liver function in health and disease.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [37]

    The Results report that hepatocyte-specific β-catenin deletion reduces hepatic ATP and increases injury after acute ethanol exposure; the Discussion also describes a reduced liver-to-body-weight ratio and delayed proliferation after partial hepatectomy. These findings support much of the comparison with β-catenin deletion, but our copy does not establish a matching effect on liver zonation. The sentence presents HSC-derived RSPO3 as the citing authors’ finding, not as a result of this source. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The β-catenin-WNT pathway promotes APAP- and CCl4-induced injury but protects from ALD, MASLD and ageing-induced injury.

    “Together, these data align with the critical role of the β-catenin–WNT pathway in liver injury, promoting APAP- and CCl4-induced injury34 but protecting from ALD36,37, MASLD35,38,39 and ageing-induced injury43.”
  • β-catenin has roles in hepatic bile acid metabolism as well as mitochondrial function and energy balance, which have been linked to increased steatosis and liver injury in mice with hepatocellular deletion of β-catenin signalling components and in non-hepatic tissues.

    “These findings match the role of β-catenin in hepatic bile acid metabolism35,39,45 as well as mitochondrial function and energy balance37,38, which have been linked to increased steatosis and liver injury in mice with hepatocellular deletion of β-catenin signalling components35,37–39 and in non-hepatic tissues46,47.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [2]Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009; 9: 327– 38. 19356714 PMC2668535
  2. [3]Liu H, Fergusson MM, Wu JJ, Rovira II, Liu J, Gavrilova O, Lu T, Bao J, Han D, Sack MN, Finkel T. Wnt signaling regulates hepatic metabolism. Sci Signal; 4: ra6. 21285411 PMC3147298
  3. [4]Xu F, Gao Z, Zhang J, Rivera CA, Yin J, Weng J, Ye J. Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/− mice: a role of lipid mobilization and inflammation. Endocrinology; 151: 2504– 14. PMC2875813 20339025
  4. [6]Ober EA, Verkade H, Field HA, Stainier DY. Mesodermal Wnt2b signalling positively regulates liver specification. Nature 2006; 442: 688– 91. 16799568
  5. [7]Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006; 131: 1561– 72. 17101329
  6. [8]Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 2005; 308: 1181– 4. 15905404
  7. [9]Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, Burgering BM. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J Biol Chem 2008; 283: 9224– 30. 18250171
  8. [10]Hoogeboom D, Burgering BM. Should I stay or should I go: beta-catenin decides under stress. Biochim Biophys Acta 2009; 1796: 63– 74. 19268509
  9. [11]Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007; 9: 210– 7. 17220880
  10. [12]Lehwald N, Tao GZ, Jang KY, Sorkin M, Knoefel WT, Sylvester KG. Wnt-beta-catenin Signaling Protects Against Hepatic Ischemia and Reperfusion Injury in Mice. Gastroenterology 2011; 141(2): 707– 18. 21679710 PMC4084974
  11. [13]Behari J, Yeh TH, Krauland L, Otruba W, Cieply B, Hauth B, Apte U, Wu T, Evans R, Monga SP. Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. Am J Pathol; 176: 744– 53. 20019186 PMC2808081
  12. [14]Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, Elledge SJ. Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev; 24: 1507– 18. PMC2904941 20634317
  13. [15]Liu S, Yeh TH, Singh VP, Shiva S, Krauland L, Li H, Zhang P, Kharbanda K, Ritov V, Monga SP, Scott DK, Eagon PK, Behari J. beta-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology. PMC3288318 22031168
  14. [16]Morris EM, Rector RS, Thyfault JP, Ibdah JA. Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal; 15: 485– 504. 21128703 PMC3118705
  15. [17]Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol; 54: 773– 94. 21145849
  16. [18]Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol; 5: 297– 348. 20078222 PMC3245719
  17. [19]Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101– 54. 7494860
  18. [20]Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999– 1007. 14512887
  19. [21]Cook WS, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Biochem Biophys Res Commun 2000; 278: 250– 7. 11071880
  20. [22]Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489– 98. 10359558 PMC408372
  21. [24]Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 2008; 105: 9793– 8. 18599449 PMC2474520
  22. [25]Purushotham A, Schug TT, Li X. SIRT1 performs a balancing act on the tight-rope toward longevity. Aging (Albany NY) 2009; 1: 669– 73. 20157548 PMC2806045
  23. [26]Carson EJ, Pruett SB. Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol Clin Exp Res 1996; 20: 132– 8. 8651442
  24. [27]Li WC, Ralphs KL, Tosh D. Isolation and culture of adult mouse hepatocytes. Methods Mol Biol; 633: 185– 96. 20204628
  25. [28]Tao GZ, Looi KS, Toivola DM, Strnad P, Zhou Q, Liao J, Wei Y, Habtezion A, Omary MB. Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis. J Cell Sci 2009; 122: 3851– 5. 19825937 PMC2773188
  26. [29]Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187– 97. 16517406
  27. [30]Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, Monga DK, Bell A, Michalopoulos GK, Monga SP. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 2005; 129: 285– 302. 16012954 PMC1821080
  28. [31]Funato Y, Michiue T, Asashima M, Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol 2006; 8: 501– 8. 16604061
  29. [32]Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 2007; 45: 361– 8. 17256747
  30. [33]Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, Monga SP. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 2009; 175: 1056– 65. 19679878 PMC2731124
  31. [34]Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. Embo J 2007; 26: 1913– 23. 17347648 PMC1847661
  32. [35]Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett 2008; 582: 46– 53. 18036349 PMC2275806
  33. [37]Simon MC. Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab 2006; 3: 150– 1. 16517402
  34. [38]An JH, Yang JY, Ahn BY, Cho SW, Jung JY, Cho HY, Cho YM, Kim SW, Park KS, Kim SY, Lee HK, Shin CS. Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells. Bone; 47: 140– 50. 20399290
  35. [39]Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH, Monga SP. Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 2008; 47: 1667– 79. 18393386 PMC4449338
  36. [41]Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 2001; 276: 68– 75. 11022051
  37. [42]Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008; 3: e2020. 18414679 PMC2289879
  38. [43]Zhang XF, Tan X, Zeng G, Misse A, Singh S, Kim Y, Klaunig JE, Monga SP. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: Role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. Hepatology. PMC3100799 20583210
  39. [44]Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003; 27: 209– 19. 15535449 PMC6668879
  40. [45]Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006; 43: S63– 74. 16447273
  41. [46]Fernandez-Checa JC. Alcohol-induced liver disease: when fat and oxidative stress meet. Ann Hepatol 2003; 2: 69– 75. 15041894

Cited by

Sorted by citations

Authors
Lehwald, N., Tao, G., Jang, K. Y., Papandreou, I., Liu, B., Liu, B., Pysz, M. A., Willmann, J. K., Knoefel, W. T., Denko, N. C., & Sylvester, K. G.
Affiliations
  • Stanford Medicine (US)
  • Jeonbuk National University Hospital (KR)
  • Heinrich Heine University Düsseldorf (DE)
  • Lucile Packard Children's Hospital (US)
Corresponding author
Sylvester, Karl G.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2012-09
Volume
143
Issue
3
Pages
754-764
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2067240474
Cited by
102
References
5
Citations by year
2026: 8 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 3 · 2018: 11 · 2017: 11 · 2016: 3 · 2015: 12 · 2014: 7 · 2013: 5
FWCI
3.09
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Children's Surgical Research Program Fund
  • Transplantation and Tissue Engineering Center
  • Packard Foundation for Children's Health
  • National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (DK56339)
  • YAEL Foundation and the German Research Foundation (DFG NL 2509/2-1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
β-catenin, Wnt signaling, hepatocytes, mitochondrial function, oxidative phosphorylation, TCA cycle, fatty acid oxidation, ATP production, ethanol intoxication, binge drinking, hepatic steatosis, oxidative stress, NAD+/NADH ratio, hepatocyte-specific knockout mice
MeSH terms
Adenosine Triphosphate, Ethanol, Animals, Citric Acid Cycle, Disease Models, Animal, Energy Metabolism, Fatty Acids, Fatty Liver, Alcoholic, Homeostasis, Mice, Inbred C57BL, Mitochondria, Liver, Oxidation-Reduction, Oxidative Phosphorylation, Time Factors, Lipid Peroxidation, Mice, Knockout, Oxidative Stress, Hepatocytes, beta Catenin, Mice, Membrane Potential, Mitochondrial, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review